Related references
Note: Only part of the references are listed.Deep interactome profiling of membrane proteins by co-interacting protein identification technology
Sandra Pankow et al.
NATURE PROTOCOLS (2016)
Breaking BAG: The Co-Chaperone BAG3 in Health and Disease
Christian Behl
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Hallmarks of therapeutic management of the cystic fibrosis functional landscape
Margarida D. Amaral et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
ΔF508 CFTR interactome remodelling promotes rescue of cystic fibrosis
Sandra Pankow et al.
NATURE (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Proteomic Analysis Reveals a Role for Bcl2-associated Athanogene 3 and Major Vault Protein in Resistance to Apoptosis in Senescent Cells by Regulating ERK1/2 Activation
Martina P. Pasillas et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
Daniela De Stefano et al.
AUTOPHAGY (2014)
Autophagy regulation by nutrient signaling
Ryan C. Russell et al.
CELL RESEARCH (2014)
Where is mTOR and what is it doing there?
Charles Betz et al.
JOURNAL OF CELL BIOLOGY (2013)
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Patrick R. Sosnay et al.
NATURE GENETICS (2013)
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator
Alessandro Luciani et al.
AUTOPHAGY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Epidermal growth factor chronically upregulates Ca2+-dependent Cl- conductance and TMEM16A expression in intestinal epithelial cells
Magdalena S. Mroz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Use of Kinase Inhibitors to Correct ΔF508-CFTR Function
Agata M. Trzcinska-Daneluti et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Cystic fibrosis: a mucosal immunodeficiency syndrome
Taylor Sitarik Cohen et al.
NATURE MEDICINE (2012)
Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Richard C. Wang et al.
SCIENCE (2012)
Endoplasmic reticulum is a main localization site of mTORC2
Delphine R. Boulbes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes
Shixiong Tan et al.
BIOCHEMICAL JOURNAL (2011)
mTOR signaling in protein homeostasis Less is more?
Crystal S. Conn et al.
CELL CYCLE (2011)
BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins
Martin Gamerdinger et al.
EMBO REPORTS (2011)
LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway
Jie Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone Availability
Shu-Bing Qian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2010)
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition
Alessandro Luciani et al.
NATURE CELL BIOLOGY (2010)
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M. Hutt et al.
NATURE CHEMICAL BIOLOGY (2010)
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
Juan M. Garcia-Martinez et al.
BIOCHEMICAL JOURNAL (2009)
The TMEM16 Protein Family: A New Class of Chloride Channels?
Luis J. V. Galietta
BIOPHYSICAL JOURNAL (2009)
TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
Jeremy Copp et al.
CANCER RESEARCH (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin
Alfredo Toschi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Hsp70 associates with Rictor and is required for mTORC2 formation and activity
Jheralyn Martin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
bag3 gene expression is regulated by heat shock factor 1
Silvia Franceschelli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
The role of the UPS in cystic fibrosis
Emma L. Turnbull et al.
BMC BIOCHEMISTRY (2007)
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis
Xiaodong Wang et al.
CELL (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics
J Rappsilber et al.
ANALYTICAL CHEMISTRY (2003)
The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
GC Meacham et al.
NATURE CELL BIOLOGY (2001)